[Effect of local immunotherapy on the production of secretory salivary immunoglobulins in gingival inflammation].
Daniel
A
A
Rezki
A
A
D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial / Q000627:therapeutic use*; D000946:Antigens, Fungal / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005035:Ethylmercury Compounds / Q000627:therapeutic use*; D005260:Female; D005891:Gingivitis / Q000188:drug therapy*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010518:Periodontitis / Q000188:drug therapy; D012463:Saliva / Q000032:analysis / Q000276:immunology; D013849:Thimerosal / Q000627:therapeutic use*
D000942:Antigens, Bacterial; D000946:Antigens, Fungal; D004338:Drug Combinations; D005035:Ethylmercury Compounds; D007070:Immunoglobulin A; C011874:imudon; D013849:Thimerosal
Activite d'une immunotherapie locale sur la production d'immunoglobulines secretoires salivaires et sur l'inflammation gingivale.